Truthout
Pharmaceutical Industry
Commercialization Is Making Access to the New COVID Vaccine More Difficult
As health care inequities deepen, pharmaceutical giants and insurers are maximizing profits.
All Manufacturers of 10 Drugs Set for Medicare Negotiation Agree to Participate
The negotiation process won't begin until early 2024, and new prices won't be implemented until two years later.
Big Pharma Raked in $82B Last Year While Lobbying Against Drug Price Proposals
The companies also upped their stock buyback and dividend payouts by nearly $7 billion last year.
Advocates Urge Schumer to “Put an End to Insulin Profiteering” in Health Package
The groups are urging Schumer to ensure that patients across the board can afford insulin.
Sanders Will Block Health Nominees Until Biden Offers Plan to Lower Drug Prices
As chair of the Senate HELP Committee, Sanders has the unilateral power to block health-related nominees.
Merck Sues Government, Saying Plan to Lower Medicare Drug Prices Is “Extortion”
The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments.
FDA Still Struggles to Inspect Foreign Drug Manufacturers After COVID Delays
A series of deaths linked to bacteria-tainted eyedrops produced overseas has raised alarm over a lag in FDA inspections.
Sanders Slams Biden for Rejecting Request to Lower Price of $190K Cancer Drug
The administration rejected a request to lower the price of prostate cancer drug Xtandi this week.
Sanders Says “Much More” Must Be Done After Insulin Maker Announces Price Cuts
Novo Nordisk is planning to cut its insulin prices by up to 75 percent, but it will still remain unaffordable for many.
Warren, Sanders: Merck’s Hunt to Extend Cancer Drug Patent May Be Patent Abuse
Merck has submitted new patents that could allow the company to maintain its monopoly on the drug until at least 2036.